Charities United Kingdom Health Genome Research Limited
Genome Research Limited logo

Genome Research Limited

Charity No 1021457 · Charity Commission Sign up to see website
Claim this charity
Ready to give?
100% goes to Genome Research Limited

GiveRadar doesn't take a cut. We couldn't find a direct donate page, so visit their site.

Visit www.sanger.ac.uk
87
Integrity Assessment
Strong transparency
87/100 · methodology

About Genome Research Limited

A) to advance research into and investigation of the human genome and to publish the useful results of such research b) to advance scientific and medical research

Founded
Size
very-large

Focus areas & reach

· What they work on and where
❤️ Health

How it stacks up against peers

· vs. 8 similar health in United Kingdom
Program spending This charity: 100%
Peer average: 97%
Integrity Assessment This charity: 87
Peer average: 89

Red flags

· All clear
Charity Commission removal
OFAC / EU / UN sanctions
Open investigations
Governance scandals
Related-party deals
Excessive exec comp

Where every £1 goes

£1.00
Program expenses£1.00 (£183.5 million)
100% to programs beats the peer average (97%) and beats the Charity Navigator "highly efficient" threshold (75%).

Common questions

· Auto-generated from filings + methodology

Genome Research Limited is a registered health nonprofit, United Kingdom. It is registered with the Charity Commission for England and Wales. It was founded in 1993 and has been operating for 33 years. It has a GiveRadar Integrity Assessment of 87/100 (Strong transparency), indicating well-documented governance, financials, and contact details. The organization reports £180M in annual revenue. 8 officers and directors are publicly disclosed. No red flags have been detected.

Genome Research Limited has a GiveRadar Integrity Assessment of 87/100. This score combines five components: Registration (20 pts), Financial Transparency (30 pts), Governance (20 pts), Contact Availability (10 pts), and Data Recency (20 pts), with negative adjustments for any red flags. A score of 87 ('Strong transparency') reflects well-documented governance, recent financials, named leadership, and working contact details. The charity allocates 100% of expenses to programs, which contributes positively to its score. For comparison, the average integrity assessment for health charities in United Kingdom is 89/100.

Genome Research Limited is registered in United Kingdom. The organization was established in 1993 and has been active for 33 years.

Based on official tax filings, Genome Research Limited has £180M in annual revenue. It allocates 100% of expenses to programs and services. This is in line with the average of 97% for health charities in United Kingdom. Its revenue is significantly above the peer average of £1M. Create a free GiveRadar account to view the complete financial breakdown with year-over-year trends.

Genome Research Limited is classified as a Health organization, registered in United Kingdom. By size, it is categorized as a very-large organization. It has £180M in annual revenue. The organization has 8 disclosed officers and directors.

No red flags have been detected for Genome Research Limited. GiveRadar automatically screens charities for concerning patterns including high executive compensation, low program spending, and missing financial filings. Based on available official data, no issues have been identified.

Genome Research Limited has a GiveRadar Integrity Assessment of 87/100 (Strong transparency) and no red flags have been detected, which suggests it is a well-documented organization. It is regulated by the Charity Commission. 100% of expenses go to programs. The peer average is 97%. Visit the Genome Research Limited profile on GiveRadar for full details before deciding. GiveRadar provides data for research purposes and does not endorse any organization. Always do your own due diligence.

A) to advance research into and investigation of the human genome and to publish the useful results of such research b) to advance scientific and medical research Genome Research Limited is classified as a health organization registered in United Kingdom. The organization was founded in 1993.

Among health charities registered in United Kingdom: Genome Research Limited's GiveRadar Integrity Assessment of 87/100 is in line with the peer average of 89/100. It allocates 100% of expenses to programs, in line with the peer average of 97%. Its annual revenue of £180M is well above the peer average of £1M.

Genome Research Limited is a registered charity in the United Kingdom. If you are a UK taxpayer, your donation may qualify for Gift Aid, which allows the charity to claim an extra 25p for every 1 pound you donate at no cost to you. Higher-rate and additional-rate taxpayers can also claim additional relief on their Self Assessment tax return.

Verified against 4 official sources, last refreshed .

Annual revenue
£100M-£1B
100% to programs
Source: Charity Commission (UK) (FY2025) why this matters
Unlock exact figures

Filing history

5 years on file from Charity Commission (UK) (FY2025): revenue, expenses, program spending, assets, and liabilities by fiscal year.

Years on record: FY2025, FY2024, FY2023, FY2022, FY2021.
Financial details are free - with a GiveRadar account

See 5 years of revenue, expense breakdowns, and balance sheet.

Sign up to view
Already have an account? Log in
No credit card · Takes 20 seconds

Taxes

Tax-deductibility for donors

UK donations qualify for Gift Aid. GENOME RESEARCH LIMITED is registered with the Charity Commission. Eligible UK taxpayers can boost their gift by 25% at no extra cost.

Always confirm tax treatment with the charity directly or your tax advisor before donating.

Leadership

CA
Caroline Relton
Trustee

Officers & trustees (8)

Source: Public filings

CA
Caroline R•••••
Trustee
DA
Daniel A•••••
Trustee
DR
Dr J•••••••• R••••••••
Trustee
DR
Dr N••••• M•••••
Trustee
KA
Karen C•••••••
Trustee
MA
Mark M•••••••
Trustee
MA
Matthew N•••••••••••••
Trustee
MI
Michael D•••
Trustee
Full names, contact details & compensation

Free with an account.

Unlock

Latest news

From global news sources

10 articles found

From global news sources

Sentiment

Neutral

Wellcome Trust appoints L&G as fiduciary manager - Pensions Age Magazine

www.pensionsage.com · · Neutral

Wellcome Trust Pension Plan appoints L&G for £800m of fiduciary mandates - Professional Pensions

www.professionalpensions.com · · Neutral

“I’m not trying to do science just for scientists. I’m doing it to try to solve important problems that will make a difference”: Jussi Taipale on genomics at scale and predicting gene expression - Wellcome Sanger Institute Blog

sangerinstitute.blog · · Neutral

Studying intracellular parasite DNA is like panning for gold - Wellcome Sanger Institute Blog

sangerinstitute.blog · · Neutral

Making genomics data more representative through Latin American research - Wellcome Sanger Institute Blog

sangerinstitute.blog · · Neutral

How our beginning is shaping our future: 25 years on from the Human Genome Project - Wellcome Sanger Institute Blog

sangerinstitute.blog · · Neutral

'Why governments need scientists' with Sir Patrick Vallance - oxfordmartin.ox.ac.uk

www.oxfordmartin.ox.ac.uk · · Neutral

Cancer genetics pioneer Professor Sir Mike Stratton to step down as Wellcome Sanger Institute director - Cambridge Independent

www.cambridgeindependent.co.uk · · Neutral

2020 vision: supporting the people behind our science - Wellcome Sanger Institute Blog

sangerinstitute.blog · · Neutral

Major U.K. genetics lab accused of misusing African DNA - Science | AAAS

www.science.org · · Mixed

Activity timeline

Filings and press mentions, merged

Wellcome Trust appoints L&G as fiduciary manager - Pensions Age Magazine
Apr 2026
www.pensionsage.com
Wellcome Trust Pension Plan appoints L&G for £800m of fiduciary mandates - Professional Pensions
Apr 2026
www.professionalpensions.com
Form filed
£180.3M revenue
FY2025
CCEW
“I’m not trying to do science just for scientists. I’m doing it to try to solve important problems that will make a diff
Oct 2025
sangerinstitute.blog
Studying intracellular parasite DNA is like panning for gold - Wellcome Sanger Institute Blog
Jul 2025
sangerinstitute.blog
Making genomics data more representative through Latin American research - Wellcome Sanger Institute Blog
Jul 2025
sangerinstitute.blog
How our beginning is shaping our future: 25 years on from the Human Genome Project - Wellcome Sanger Institute Blog
Jun 2025
sangerinstitute.blog
Form filed
£177.3M revenue
FY2024
CCEW
'Why governments need scientists' with Sir Patrick Vallance - oxfordmartin.ox.ac.uk
May 2024
www.oxfordmartin.ox.ac.uk
Form filed
£189.0M revenue
FY2023
CCEW
Form filed
£185.9M revenue
FY2022
CCEW
Cancer genetics pioneer Professor Sir Mike Stratton to step down as Wellcome Sanger Institute director - Cambridge Indep
Feb 2022
www.cambridgeindependent.co.uk
Form filed
£221.5M revenue
FY2021
CCEW
2020 vision: supporting the people behind our science - Wellcome Sanger Institute Blog
Jan 2020
sangerinstitute.blog
Major U.K. genetics lab accused of misusing African DNA - Science | AAAS
Oct 2019
www.science.org

No reviews yet. Be the first to share your experience.

Have you donated or volunteered here?

Share your experience - it takes 30 seconds. Verified reviews help other donors decide.

Sign up to write a review

Peer charities

Other health in United Kingdom, by integrity assessment

Charity Score Revenue Program %
Genome Research Limited This page 87 £180.3 million 100%
Compassion in Action 89 £800,706 100%
West Sussex Mind 89 £3.6 million 96%
Worcestershire Association of Carers 89 £1.5 million 93%
Helpforce Community 89 £1.6 million 96%
Headway Birmingham & Solihull 89 £2.2 million 93%
Emmaus Bristol 89 £788,306 98%
The Peaceful Place Ltd 89 £748,485 98%
Hoxton Hall 89 £825,165 100%

Sources and verification

Refreshed

Registration and legal identity
Charity Commission for England and Wales - Register of Charities
Financial filings
Charity Commission annual returns - Fiscal year 2025 most recent on file.
Officers and trustees
Charity Commission for England and Wales - Register of Charities - 8 disclosed in the public registry.
News and media coverage
GDELT Project + Google News

Data freshness

Last updated
Mar 5, 2026
Profile completeness
85%

What we don't know

Honest gaps - our score reflects transparency, not impact

Executive compensation
Top-officer pay not disclosed
Mission statement
No self-published statement of purpose
Programs & projects
No named programs listed by the charity
Headquarters address
No street address on file
Operating reach
Countries where programs run not specified
Programmatic detail
Specific cause areas not yet tagged

Methodology

GiveRadar combines public registry filings, ProPublica Nonprofit Explorer, Charity Navigator, GuideStar, and news archives into a single 0-100 integrity assessment. We don't take a cut of any donation, ever.

Read full methodology

Quick facts about Genome Research Limited

What is Genome Research Limited?
Genome Research Limited is a health nonprofit organization, United Kingdom. A) to advance research into and investigation of the human genome and to publish the useful results of such research b) to advance scientific and medical research
When was Genome Research Limited founded?
Genome Research Limited was founded in 1993.
Where is Genome Research Limited located?
Headquartered in United Kingdom.
What is Genome Research Limited's annual budget?
Annual revenue for fiscal year 2025 is approximately £100M-£1B. 100% of expenses go to program services.
Is Genome Research Limited trustworthy?
Genome Research Limited has a GiveRadar Integrity Assessment of 87 out of 100 (Strong transparency). The score reflects public-data transparency: registration, financial disclosure, governance, contact details, and how recently data was refreshed. It does not measure program impact.
What is Genome Research Limited's website?
https://www.sanger.ac.uk
Are donations to Genome Research Limited tax-deductible?
Donations may be tax-deductible for residents of United Kingdom under local rules. US donors should check whether the charity has an equivalency-determination letter or a US-based fiscal sponsor before claiming a deduction.